Actually, HD patients with coexisting type 2 diabetes treated with metformin experienced an enhancement of cognitive functions, suggesting that the pharmacological stimulation of AMPK could serve as a viable approach in addressing HD [63,64]. The gene discussed is PRKAB1; the disease is Huntington disease.